The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I trial of palbociclib and paclitaxel in metastatic breast cancer.
Amy Sanders Clark
No relevant relationships to disclose
Peter J. O'Dwyer
No relevant relationships to disclose
Daniel Heitjan
No relevant relationships to disclose
Priti Lal
No relevant relationships to disclose
Michael D Feldman
No relevant relationships to disclose
Maryann Gallagher
No relevant relationships to disclose
Colleen Redlinger
No relevant relationships to disclose
Christopher Colameco
No relevant relationships to disclose
David Lewis
No relevant relationships to disclose
Kelly Zafman
No relevant relationships to disclose
Melissa Langer
No relevant relationships to disclose
Mark Alan Rosen
No relevant relationships to disclose
Keerthi Gogineni
No relevant relationships to disclose
Angela R. Bradbury
No relevant relationships to disclose
Susan M. Domchek
No relevant relationships to disclose
Kevin R. Fox
No relevant relationships to disclose
Angela DeMichele
No relevant relationships to disclose